Tens of thousands of Australians living with chronic kidney disease will soon have access to more cheaper medicines on the Pharmaceutical Benefits ...

A diabetes drug that helps to slow kidney damage will be made available to more people more cheaply from Saturday, in the ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...

The latest edition of the Patented Medicine Prices Review Board (PMPRB) CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

Being diagnosed with Alzheimer’s disease or mild cognitive impairment can be overwhelming. These conditions slowly affect ...

Type 2 diabetes patients starting on SGLT2 inhibitors had a sightly lower risk of autoimmune rheumatic diseases compared with ...

Currently, there‘s no universal Medicare drug price list available, as drug costs and availability vary according to the private insurer administering the Part D prescription drug plan. Contact Part D ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide further reduced risk for stroke vs. empagliflozin as treatment for diabetes. Dulaglutide’s impact on ...